Alector, Inc.

Home » Alector, Inc.

IPO

Alector, Inc.

We are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.

Symbol

ALEC

Price Range
$18.00 - $20.00

Final Shares
9,250,000

Effective Date
February 7, 2019

Underwriters
Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays

To view the prospectus for Alector, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253